Innovation in Compliance: LeadHERship with Linda Fisk
PODCAST: Williams Mullen's Raising Capital 101: A Securities Podcast - What are the Different Ways Securities Can Be Offered and Sold? (Part 1)
Podcast: The Briefing by The IP Law Blog - Court Rules Litigation Funding Not Relevant in Netflix v. GoTV
The Briefing by The IP Law Blog: Court Rules Litigation Funding Not Relevant in Netflix v. GoTV
Spending New York’s $4.2 Billion Environmental Bond Funds
Arm's Length Principle Vs. Implicit Support: What's the Way Forward?
Inside DC Podcast: FY2022 Budget Recap and the DC Council’s Fall Agenda
Fast Track to IPO: Why Are Series A Startups Snatching Topflight CFOs?
FCPA Compliance and Ethics Report-Episode 175-Debra Bruce on new methods for law firm funding and its implications
IP|Trend: Starting Up Your Protection of Intellectual Property
PV Project Finance in Latin America is Easy, Right?
Navigating the Dual Track M&A/IPO– Part One
The Shift to Angel Investors – Interview with Jeremy Glaser, Member, Mintz Levin
Financing Trends in Life Sciences – Interview with Bill Whelan, Member, Mintz Levin
Jobs, Funding For Courts On Agenda For New ABA President
The life sciences industry is built on breakthroughs and partnerships. From early-stage biotech startups to established medtech and pharma companies, success often depends on navigating complex business transactions, securing...more
Goodwin’s 2025 Rare Disease Symposium, held on February 5 in Boston and virtually, gathered patient advocates and caregivers, providers, researchers, biotech and medtech leaders, investors, and policy experts to discuss the...more
The life sciences industry depended historically on public offerings for fundraising to support costs of developing therapeutic pharmaceutical and biologic products. The average cost of discovering and developing these...more
Hosted by American Conference Institute (ACI), the National Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies will highlight leveraging technology, safeguarding IP, and securing...more
Early-stage and small to midsize private and public companies in the life sciences sector began 2020 on a high note. Funding, particularly in the biotechnology sector, was pouring into the industry. Even several months into...more